Condensed Statements of Shareholders' Equity - USD ($)	Common Stock	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020	$ 34,006,218	$ (34,019,697)	$ (13,479)
Balance at the beginning (in shares) at Dec. 31, 2020	17,707,472
Net loss for the period		(11,777)	(11,777)
Balance at the end at Mar. 31, 2021	$ 34,006,218	(34,031,474)	(25,256)
Balance at the end (in shares) at Mar. 31, 2021	17,707,472
Balance at the beginning at Dec. 31, 2020	$ 34,006,218	(34,019,697)	(13,479)
Balance at the beginning (in shares) at Dec. 31, 2020	17,707,472
Net loss for the period			(21,444)
Balance at the end at Sep. 30, 2021	$ 34,015,951	(34,041,141)	(25,190)
Balance at the end (in shares) at Sep. 30, 2021	17,866,871
Balance at the beginning at Mar. 31, 2021	$ 34,006,218	(34,031,474)	(25,256)
Balance at the beginning (in shares) at Mar. 31, 2021	17,707,472
Sale of common stock	$ 6,989		6,989
Sale of common stock (in shares)	133,626
Net loss for the period		(4,256)	(4,256)
Balance at the end at Jun. 30, 2021	$ 34,013,207	(34,035,730)	(22,523)
Balance at the end (in shares) at Jun. 30, 2021	17,841,098
Sale of common stock	$ 2,744		2,744
Sale of common stock (in shares)	25,773
Net loss for the period		(5,411)	(5,411)
Balance at the end at Sep. 30, 2021	$ 34,015,951	(34,041,141)	(25,190)
Balance at the end (in shares) at Sep. 30, 2021	17,866,871
Balance at the beginning at Dec. 31, 2021	$ 34,033,975	(34,047,065)	(13,090)
Balance at the beginning (in shares) at Dec. 31, 2021	17,987,031
Sale of common stock	$ 2,367		2,367
Sale of common stock (in shares)	18,208
Net loss for the period		(13,869)	(13,869)
Balance at the end at Mar. 31, 2022	$ 34,036,342	(34,060,934)	(24,592)
Balance at the end (in shares) at Mar. 31, 2022	18,005,239
Balance at the beginning at Dec. 31, 2021	$ 34,033,975	(34,047,065)	(13,090)
Balance at the beginning (in shares) at Dec. 31, 2021	17,987,031
Net loss for the period			(27,374)
Balance at the end at Sep. 30, 2022	$ 34,046,535	(34,074,439)	(27,904)
Balance at the end (in shares) at Sep. 30, 2022	18,058,037
Balance at the beginning at Mar. 31, 2022	$ 34,036,342	(34,060,934)	(24,592)
Balance at the beginning (in shares) at Mar. 31, 2022	18,005,239
Sale of common stock	$ 1,310		1,310
Sale of common stock (in shares)	6,550
Net loss for the period		(5,939)	(5,939)
Balance at the end at Jun. 30, 2022	$ 34,037,652	(34,066,873)	(29,221)
Balance at the end (in shares) at Jun. 30, 2022	18,011,789
Sale of common stock	$ 8,883		8,883
Sale of common stock (in shares)	46,248
Net loss for the period		(7,566)	(7,566)
Balance at the end at Sep. 30, 2022	$ 34,046,535	$ (34,074,439)	$ (27,904)
Balance at the end (in shares) at Sep. 30, 2022	18,058,037